Business Overview
The convergence of physical structural engineering and biological computation.
Living Systems Intelligence (LSI)
The LSI division focuses on the intelligent design of biological interfaces. By leveraging proprietary bio-synthetic frameworks, LSI ensures that therapeutic interactions are precisely managed at the cellular level, drastically reducing systemic toxicity and increasing efficacy.
CytosAI (Computational Biology)
CytosAI utilizes a proprietary generative transformer model trained on 500PB of proprietary proteomic data. It predicts protein folding and interaction specifically within the LSI-Matrix environment, reducing drug discovery timelines by approximately 70%.
Strategic Flywheel
Data generated from LSI's physical applications feeds directly into CytosAI's training models. Conversely, CytosAI optimizes the composition of LSI matrices for specific patient profiles. This closed-loop data advantage creates a widening competitive moat.